What is the Treatment Abroad Scheme

The HSE operates a Treatment Abroad Scheme (TAS) for people entitled to treatment in another EU/EEA member state.

You can download an application form for the Treatment Abroad Scheme. If you would like us to send you a form you can email us at treatmentabroad.scheme@hse.ie. You can also contact us by telephone.Europe

The TAS provides the cost of approved treatments in another EU/EEA member state or Switzerland. The scheme allows a Consultant based in Ireland to refer a patient that is normally resident in Ireland for treatment in another EU member state or Switzerland, where the treatment in question meets the following criteria:

(a) The application to refer a patient abroad has been assessed and a determination given before that patient goes abroad.

(b) Following clinical assessment, the referring Consultant certifies the following:
- They recommend the patient be treated in another EU/EEA country or Switzerland;
- The treatment is medically necessary and will meet the patient's needs;
- The treatment is a proven form of medical treatment and is not experimental or test treatment;
- The treatment is in a recognised hospital or other institution and is under the control of a registered medical practitioner;
- The hospital outside the state will accept EU/EEA form E112 (IE).

Access scheme Apply icon
Patient needs Consultant needs
Travel FAQ 3

The TAS Office

The TAS office will return any incomplete applications to the patient/applicant outlining information needed. The TAS office aims to provide a decision on an application within 15 to 20 working days. The TAS office will notify the patient/applicant and the Consultant of the decision by letter.

The Treatment Abroad Scheme (TAS), is governed by EU Regulation 1408/71, as per the procedures set out in EU Regulation 574/72, and in accordance with Department of Health and Children Guidelines.